imac memory slots
April 17, 2008 -- A nearly forgotten allergy drug first used in Russia more than two decades ago is showing promise for the treatment of Alzheimer's disease. In a study of the antihistamine Dimebon, Alzheimer's patients with mild to moderate disease continued to show improvements in memory, thinking, and daily and overall functioning over six months of treatment. Some patients showed improvements when treated for up to a year. Results from the Russian study were presented this week at the 60th annual meeting of the American Academy of Neurology (AAN) in Chicago. Study results were also reported last summer at an international conference on Alzheimer's disease. Dimebon Alzheimer's Trial Dimebon was approved as an antihistamine in Russia in the early 1980s. It attracted attention as a potential Alzheimer's treatment following positive animal studies in 2000. casino games play only card counting online casinos online super cherry video slots no download free slot machine play
